Researchers: BMP Doesn’t Improve Long-Term Outcomes

A new analysis of 18 studies about the use of bone morphogenic protein for lumbar fusions show the product doesn’t significantly improve outcomes, according to a report in AAOS Now.

Advertisement

Evalina Burger, MD, and her colleagues presented the results of the analysis, which included studies from seven different countries, at the AAOS annual meeting. The data showed:

•    Significant improvement in disability, pain and physical health after fusion regardless of whether BMP was used;
•    Fusion rates were high and similar among BMP and non-BMP groups;
•    Both groups failed to improve employment rate after surgery;
•    BMP was not associated with increased complications.

The studies followed patients for 24-48 months after surgery.

More Articles on Spine Surgery:

15 Spine Surgeons Discuss Patient Satisfaction

Scoliosis Research Society Letter Protests BCBS of Minnesota

Washington University School of Medicine Names Dr. Lawrence Lenke Chief of Spinal Surgery

Advertisement

Next Up in Spine

Advertisement

Comments are closed.